Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-533-5 | CAS number: 584-13-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22.06. - 24.06. 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 021
- Report date:
- 2021
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Version / remarks:
- Adopted: 26 June 2020, Appendix I: The Direct Peptide Reactivity Assay (DPRA)
- Deviations:
- yes
- Remarks:
- error by typo, with no influence on result (see Overall remarks, attachments)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- 4H-1,2,4-triazol-4-ylamine
- EC Number:
- 209-533-5
- EC Name:
- 4H-1,2,4-triazol-4-ylamine
- Cas Number:
- 584-13-4
- Molecular formula:
- C2H4N4
- IUPAC Name:
- 4H-1,2,4-triazol-4-ylamine
- Test material form:
- solid
Constituent 1
In chemico test system
- Details of test system:
- cysteine peptide, (Ac-RFAACAA-COOH)
- lysine peptide (Ac-RFAAKAACOOH)
- Details on the study design:
- PREPARATION OF TEST SOLUTIONS
- Preparation of the peptide/derivative stock solutions
Preparation of peptide stock solution (approx. 0.667 mM)
The necessary volume of peptide solution was estimated. (800 µl of peptide stock solution is needed for preparation of one analysed solution). 20 ml of the stock solution of Cysteine and Lysine peptide (0.667 mM) were prepared.
20 ml of phosphate buffer, pH = 7.5 was added to 10.06 mg of the Cysteine peptide. The concentration of Cysteine peptide in the stock solution was 0.6699 mM. 20 ml of ammonium acetate buffer, pH = 10.2 was added to 10.60 mg of the Lysine peptide. The concentration of Lysine peptide in the stock solution was 0.6831 mM. The amount of buffer was added to individual peptides just before testing itself.
Using serial dilution, standard solutions were prepared of the Cysteine peptide stock solution covering the range from 0.0167 - 0.5359 mM.
Using serial dilution, standard solutions were prepared of the Lysine peptide stock solution covering the range from 0.0171 - 0.5465 mM.
- Preparation of the test chemical solutions
Theoretical weight of 4H-1,2,4-triazol-4-amine is 25.48 mg ± 10%.
The weighed amount of 4H-1,2,4-triazol-4-amine was dissolved in 3 ml of ACN.
The weighed amount of 4H-1,2,4-triazol-4-amine was 42.49 mg for Cysteine peptide analysis. The weighed amount of 4H-1,2,4-triazol-4-amine was 42.57 mg for Lysine peptide analysis.
- Preparation of the positive controls, reference controls and co-elution controls
A positive control: 100 mM solution of cinnamaldehyde. The weighed amount of cinnamaldehyde (approximately 40.13 ± 10 % mg) was dissolved in 3 ml of acetonitrile.
A negative control: 100 mM solution of 1-butanol. The weighed amount of 1-butanol (approximately 22.5 ± 10 % mg) was dissolved in 3 ml of acetonitrile.
Reference Control A was made with acetonitrile and used to verify the accuracy of the calibration curve for peptide quantification.
Reference Control B was made with acetonitrile and its replicates were injected in the beginning and in the end of the experimental run to verify the stability of the peptide over the analysis time.
Reference Controls C were made with acetonitrile (solvent used for dissolving the positive, negative controls and test item). They are used to verify that the solvent used to dissolve the test item does not any impact the percent peptide depletion. The Reference Controls C are used to calculate percent peptide depletion.
Co-elution control was constituted by the test item without the addition of peptides. Instead of the addition of peptides, the appropriate amount of buffer was added. The co-elution test serves to verify that the test item does not have the same retention time as peptides and does not absorb at 220 nm as the Cysteine and Lysine peptides.
INCUBATION
- Incubation conditions
The vials were closed, mixed and placed in the HPLC autosampler (dark) at 25 °C for 24 ± 2 hours.
- Precipitation noted: no
PREPARATION OF THE HPLC
- Standard calibration curve for both Cys and Lys
A standard calibration curve was generated for both the Cysteine and the Lysine peptides.
Linearity was determined by mathematical treatment of results obtained by analysis of standard solutions ( report chapter 3.5.6. and 3.5.7.) The concentration interval of the standard solutions was 0.0167 - 0.5359 mM for Cysteine peptide and 0.0171 - 0.5465 mM for Lysine peptide.
Each prepared calibration solution was analysed by HPLC with DAD detection.
- Verification of the suitability of the HPLC for test chemical and control substances
The criteria of quality in accordance with the OECD TG 442C were fulfilled.
DATA EVALUATION
The Cysteine and Lysine peptide concentrations were determined at a 220 nm by evaluating of their peak area in samples and calculating from the linear calibration curve constructed from the standard solutions
The Cysteine 1:10/Lysine 1:50 prediction model was used based on the experimental results .
The mean of Cysteine and Lysine percent depletion value is 1.4 %.
The test item 4H-1,2,4-triazol-4-amine was included in the reactivity class – No or minimal reactivity and was determined as Negative in the DPRA prediction. - Vehicle / solvent:
- acetonitrile
- Positive control:
- cinnamic aldehyde
Results and discussion
- Positive control results:
- The mean percent peptide depletion value at 220 nm for the positive control Cinnamaldehyde is 70.8 % for the Cysteine peptide.
The mean percent peptide depletion value at 220 nm for the positive control Cinnamaldehyde is 65.3 % for the Lysine peptide.
In vitro / in chemico
Resultsopen allclose all
- Key result
- Group:
- test chemical
- Run / experiment:
- mean
- Parameter:
- cysteine depletion
- Value:
- 2.3 %
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Group:
- test chemical
- Run / experiment:
- mean
- Parameter:
- lysine depletion
- Value:
- 0.5 %
- Negative controls validity:
- valid
- Positive controls validity:
- valid
Applicant's summary and conclusion
- Interpretation of results:
- other: sensitisation potential predicted in the ARE-Nrf2 Luciferase Test Method, another in vitro test is needed
- Conclusions:
- All study acceptance criteria have been successfully met.
The test item, 4H-1,2,4-triazol-4-amine, has been found negative in the DPRA prediction; it was assigned to reactivity class “No or minimal reactivity”.
The data generated with this test should be considered in the context of integrated approached such as IATA, combining the result with other complementary information, e.g. derived from in vitro assays addressing other key events of the skin sensitisation AOP. - Executive summary:
The purpose of the test is to contribute to the evaluation of the skin sensitisation potential of 4H-1,2,4-triazol-4-amine. This study is a part of this test item health hazard evaluation for registration of industrial chemicals.
The test was performed according to OECD TG 442C, In Chemico Skin Sensitisation: Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins, Adopted: 26 June 2020, Appendix I: The Direct Peptide Reactivity Assay (DPRA)
In the study, 4H-1,2,4-triazol-4-amine was dissolved in acetonitrile, based on the results of the pre-experiments. The stock solution at concentration 167 mM was prepared based on a molecular weight of 84.08 g/mol.
The test item solutions were tested by incubating the samples with synthetic heptapeptides containing either cysteine or lysine at 25 °C for 24 ± 2 hours. Depletion of the peptide in the reaction mixture was measured by HPLC with UV detection. Average peptide depletion data for cysteine and lysine were calculated. Cinnamaldehyde (100 mM) was used as a positive control and 1-butanol (100 mM) was used as a negative control. Each test chemical was prepared and analysed in triplicate for both peptides.
Samples were visually inspected prior to the start of incubation and prior to HPLC analysis.
Immediately after addition of the Cysteine peptide to the solutions, there were not any turbity or cloudiness, any colour changes in the vials. There were not any turbity or cloudiness, any colour changes in the vials after 24-hour incubation.
Immediately after addition of the Lysine peptide to the positive control, slight whitish turbidity was observed in the vial. The other vials were clear. The yellowish sediment on the bottom and on the wall of the vials with positive control was presented after 24-hour incubation. The other vials were clear with no color change, no turbidity and no precipitate in the vial.
All study acceptance criteria have been successfully met.
The mean of Cysteine and Lysine percent depletion values is 1.4 %. Based on the obtained results, the prediction model the Cysteine 1:10/Lysine 1:50 was used for evaluation. The test item, 4H-1,2,4-triazol-4-amine, has been found negative in the DPRA prediction; it was assigned to reactivity class “no or minimal reactivity” for both peptides.
The data generated with this test should be considered in the context of integrated approached such as IATA, combining the result with other complementary information, e.g. derived from in vitro assays addressing other key events of the skin sensitisation AOP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.